| Subject: | FDA Approves First U.S. Vaccine for Humans Against the Avian Influenza Virus H5N1 |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Tue, 24 Apr 2007 - 12:00 am |
| The FDA has announced the first approval in the United States of a vaccine for humans against the H5N1 influenza virus, commonly known as avian or bird flu. The approval and availability of this vaccine will enhance national readiness for a H5N1 Influenza pandemic and increase the nation's ability to protect those at risk of exposure to H5N1. The manufacturer, Sanofi Pasteur Inc., will not sell the vaccine commercially. Instead, the vaccine has been purchased by the federal government for... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
Related MCN Products:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. The strength of StayAlert! rests in its ability to allow healthcare organizations to streamline their businesses using the Internet as a foundation architecture. StayAlert! provides cost containment and reduction through elimination of unnecessary overhead, and work caused by errors or poor access to information. |
|
